127
edits
No edit summary |
m (Included therapeutic range) |
||
| Line 1: | Line 1: | ||
{| class="wikitable" | {| class="wikitable" | ||
|''' | |'''Parameter''' | ||
| | |'''Units''' | ||
| | |'''Normal range''' | ||
|'''Therapeutic range''' | |||
|- | |- | ||
|INR | |INR | ||
|Ratio | |Ratio | ||
|0.8 - 1.2 | |0.8 - 1.2 | ||
|2.0 - 3.0* | |||
|- | |- | ||
|APTT | |APTT | ||
|Seconds | |Seconds | ||
|24-38 | |24-38 | ||
|50 - 85 secs | |||
|- | |- | ||
|FIBRINOGEN | |FIBRINOGEN | ||
|g/L | |g/L | ||
|1.5-4.0 | |1.5-4.0 | ||
|N/A | |||
|- | |- | ||
|TCT | |TCT | ||
|Seconds | |Seconds | ||
|15 - 21 | |15 - 21 | ||
|N/A | |||
|- | |||
|D DIMER | |||
|ug/L | |||
|< 500 | |||
|N/A | |||
|- | |||
|FVIII | |||
|iu/dl | |||
|50 - 200 | |||
|N/A | |||
|} | |} | ||
<nowiki>*</nowiki><small>The INR therapeutic range may be higher for conditions such as heart valves, recurrent thromboembolism or arterial thromboembolism with associated antiphospholipid syndrome.</small> | |||
edits